According to Polaris Market Research, the global nanorobotics market is projected to reach $31.44 billion by 2034, up from an estimated $9 billion in 2025, representing a compound annual growth rate of 14.9%. The growth is fueled by expanding applications in targeted drug delivery, precision medicine, and regenerative medicine.
Key takeaways
- Drug delivery is the largest commercial application, with recent research demonstrating significant preclinical results: DNA-based nanorobots reduced tumor growth by 70%, autonomous therapeutic nanorobots cut bladder tumors by up to 90%, and modular self-assembling nanorobots lowered cancer cell viability to 16%.
- Cell-repair nanorobots are the fastest-growing device category, while regenerative medicine is the fastest-growing application area, driven by stem cell therapies, tissue engineering, and organoid research.
- North America holds about 41% of the market, but Asia Pacific is expected to grow fastest at nearly 19% annually, supported by biotech investments in China, Japan, South Korea, and India.
- Key players include Thermo Fisher Scientific, Bruker, Oxford Instruments, JEOL, and Park Systems, with potential consolidation as the industry shifts from imaging to therapeutic applications.
For manufacturers and system integrators, the findings signal growing demand for nanoscale automation and precision handling systems, particularly in medical and biotech sectors. The shift toward therapeutic nanorobots may open new integration opportunities in laboratory automation and scalable production of nanodevices.
Source: Robotics & Automation News (roboticsandautomationnews.com) · Published 2026-08-21 · “Nanorobotics market forecast to grow to $31.4 billion by 2034”